Comparative prognostic importance of measures of left atrial structure and function in non-ischaemic dilated cardiomyopathy
- PMID: 38492215
- PMCID: PMC11522868
- DOI: 10.1093/ehjci/jeae080
Comparative prognostic importance of measures of left atrial structure and function in non-ischaemic dilated cardiomyopathy
Abstract
Aims: This study aimed to compare the association between measures of left atrial (LA) structure and function, derived from cardiovascular magnetic resonance (CMR), with cardiovascular death or non-fatal heart failure events in patients with non-ischaemic dilated cardiomyopathy (DCM).
Methods and results: CMR studies of 580 prospectively recruited patients with DCM in sinus rhythm [median age 54 (interquartile range 44-64) years, 61% men, median left ventricular ejection fraction 42% (30-51%)] were analysed for measures of LA structure [LA maximum volume index (LAVImax) and LA minimum volume index (LAVImin)] and function (LA emptying fraction, LA reservoir strain, LA conduit strain (LACS), and LA booster strain]. Over a median follow-up of 7.4 years, 103 patients (18%) met the primary endpoint. Apart from LACS, each measure of LA structure and function was associated with the primary endpoint after adjusting for other important prognostic variables. The addition of each LA metric to a baseline model containing the same important prognostic covariates improved model discrimination, with LAVImin providing the greatest improvement [C-statistic improvement: 0.702-0.738; χ2 test comparing likelihood ratio P < 0.0001; categorical net reclassification index: 0.210 (95% CI 0.023-0.392)]. Patients in the highest tercile of LAVImin had similar event rates to those with persistent atrial fibrillation. Measures of LA strain did not enhance model discrimination above LA volumetric measures.
Conclusion: Measures of LA structure and function offer important prognostic information in patients with DCM and enhance the prediction of adverse outcomes. LA strain was not incremental to volumetric analysis for risk prediction.
Keywords: dilated cardiomyopathy; left atrium; risk prediction; strain.
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: R.B. has received honoraria from AstraZeneca, Vifor, and Medtronic. K.G. has received honoraria from Bayer, Pfizer, Novartis, AstraZeneca, and Servier Laboratories, a previous unrestricted educational grant from Biotronik, and previous travel assistance from Abbott Laboratories, Medtronic, Biotronik, and Boston Scientific. J.S.W. has acted as a consultant for MyoKardia, Foresite Labs, and Pfizer. D.J.P. has received research funding from Siemens. B.P.H. has received honoraria from Astra Zeneca. The other authors have nothing to declare.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                Comment in
- 
  
  Left atrial volume as risk marker: is minimum volume superior to maximum volume?Eur Heart J Cardiovasc Imaging. 2024 Oct 30;25(11):1575-1576. doi: 10.1093/ehjci/jeae136. Eur Heart J Cardiovasc Imaging. 2024. PMID: 38781443 Free PMC article. No abstract available.
References
- 
    - Merlo M, Cannatà A, Pio Loco C, Stolfo D, Barbati G, Artico J et al. Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy. Eur J Heart Fail 2020;22:1111–21. - PubMed
 
- 
    - Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077–84. - PubMed
 
- 
    - Gulati A, Ismail TF, Jabbour A, Ismail NA, Morarji K, Ali A et al. Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy. Eur J Heart Fail 2013;15:660–70. - PubMed
 
- 
    - Rossi A, Cicoira M, Zanolla L, Sandrini R, Golia G, Zardini P et al. Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002;40:1425–30. - PubMed
 
- 
    - Negishi K, Pathan F. Novel left atrial markers for risk stratification of heart failure. J Am Coll Cardiol 2022;79:1562–4. - PubMed
 
Publication types
MeSH terms
Grants and funding
- MRC_/Medical Research Council/United Kingdom
- National Institute for Health Research
- FS/CRTF/23/24444/BHF_/British Heart Foundation/United Kingdom
- NIHR Imperial College Biomedical Research Centre
- MR/W023830/1/MRC Clinician Scientist Fellowship
- British Society for Heart Failure Research Fellowship
- FS/ICRF/21/26019/BHF Intermediate Clinical Research Fellowship
- Royston Centre for Cardiomyopathy Research
- FS/CRTF/23/24444/British Heart Foundation Clinical Research Training Fellowship
- Royal Brompton Cardiovascular Biomedical Research Unit
- National Heart and Lung Institute Foundation
- Rosetrees Trust
- Alexander Jansons Myocarditis UK Foundation
- 21JTA/Sir Jules Thorn Charitable Trust
- RE/18/4/34215/BHF_/British Heart Foundation/United Kingdom
LinkOut - more resources
- Full Text Sources
- Miscellaneous
 
        